Powered by

Novel Oral Antibiotic Treatment Seysara(TM) (sarecycline) Now Available

Jan 17, 2019 - PR Newswire

PR Newswire

 Almirall LLC announces the launch of Seysara(TM) (sarecycline), a novel tetracycline-derived oral antibiotic developed specifically for the treatment of acne. Seysara(TM) was approved in October 2018 by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe non-nodular inflammatory acne vulgaris in patients 9 years of age and older, and is now commercially available.

"Seysara(TM) was the first new chemical entity for the treatment of acne t...